X
Xiaozhong Guo
Researcher at Liaoning University of Traditional Chinese Medicine
Publications - 164
Citations - 3111
Xiaozhong Guo is an academic researcher from Liaoning University of Traditional Chinese Medicine. The author has contributed to research in topics: Cirrhosis & Portal vein thrombosis. The author has an hindex of 28, co-authored 142 publications receiving 2269 citations.
Papers
More filters
Journal ArticleDOI
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.
TL;DR: A systematic review and meta-analysis aimed to compare the discriminative ability of Child–Pugh versus MELD score to assess the prognosis of cirrhotic patients and found that their benefits might be heterogeneous in some specific conditions.
Journal ArticleDOI
Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies
TL;DR: Anticoagulation could achieve a relatively high rate of portal vein recanalization in cirrhotic patients with PVT, given that only a small number of non-randomized comparative studies are reported, randomized controlled trials are warranted to confirm the risk-to-benefit of anticoagulant therapy in such patients.
Journal ArticleDOI
Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis
TL;DR: APRI, AAR, FIB-4, Lok, and Forns scores had low to moderate diagnostic accuracy in predicting the presence of varices in liver cirrhosis.
Journal ArticleDOI
Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
TL;DR: NLR should be a major prognostic factor for HCC patients and might be further incorporated into the prognostic model of HCC.
Journal ArticleDOI
Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
Yanyan Wu,Hongyu Li,Xiaozhong Guo,Eric M. Yoshida,Nahum Méndez-Sánchez,Giovanni Battista Levi Sandri,Rolf Teschke,Fernando Gomes Romeiro,Akash Shukla,Xingshun Qi +9 more
TL;DR: Abnormal liver biochemical tests are common in COVID-19 patients and are closely related to the severity and prognosis of patients, and non-survivors had a significantly higher incidence than survivors of abnormal liver biochemical indicators.